Palisade Bio Inc (NASDAQ:PALI)
| 1.40 Delayed Data As of Jun 02 |  -0.04 / -2.78%Today’s Change | 1.27 Today|||52-Week Range 31.00 | -73.08% Year-to-Date |
Latest PALI News | Press Releases
| Palisade Bio, Inc. (PALI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now May 23 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.44 |
| Today’s open | 1.41 |
| Day’s range | 1.38 - 1.44 |
| Volume | 1,280 |
| Average volume (3 months) | 1,364,503 |
| Market cap | $9.3M |
Data as of 3:59pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | +88.44% |
| Earnings growth (this year) | +89.23% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CBIOCatalyst Biosciences... | +0.03 | +12.83% |
| AGLEAeglea Bio Therapeut... | -0.00 | -2.45% |
| CWBRCohBar Inc | +0.15 | +5.56% |
| NMTR9 Meters Biopharma I... | +0.00 | +0.45% |
Data as of 4:00pm ET, 06/02/2023
Financials
| Next reporting date | August 22, 2023 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$14.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Carlsbad, California |
Forecasts
